Dr. Bratman is Scientist at Princess Margaret Cancer Centre Research Institute and Assistant Professor of Radiation Oncology & Medical Biophysics at the University of Toronto. He received his MD and PhD from Columbia University in 2009 followed by postdoctoral research and clinical training at Stanford Cancer Institute. Since joining The Princess Margaret in 2014, Dr. Bratman has served as Staff Radiation Oncologist within the Wharton Head and Neck Centre and has led basic, translational, and clinical research studies on head and neck cancer and circulating biomarkers.
Dr. Bratman's primary research focus is on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. His laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer.
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Genome Med. 2019 04 19;11(1):22
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Int J Radiat Oncol Biol Phys. 2019 Mar 08;:
Human Papillomavirus and p16 Immunostaining, Prevalence and Prognosis of Squamous Carcinoma of Unknown Primary in the Head and Neck Region.
Int J Cancer. 2019 Jan 30;:
Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis.
Nat Commun. 2018 11 30;9(1):5116
Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.
Blood. 2018 Nov 16;:
Nature. 2018 Nov 14;:
Eat Weight Disord. 2018 Nov 09;:
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.
Cell Rep. 2018 Oct 30;25(5):1318-1331.e4
Scientist, Princess Margaret Cancer Centre
Assistant Professor, Department of Medical Biophysics, University of Toronto
Assistant Professor, Department of Radiation Oncology, University of Toronto